Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin
Melinda Poole, Brian Lee Claggett, Robin Myte, Dustin J. Little et al.
Journal
Circulation Heart Failure
Topics
Advanced Causal Inference Techniques
article
Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin
Melinda Poole, Brian Lee Claggett, Robin Myte, Dustin J. Little, John J.V. McMurray, Alasdair Henderson, Samvel B. Gasparyan, Scott David Solomon, Andrea Mattsson, Per Nyström
article en
Abstract
No abstract available for this paper.
Publication Tag
Circulation Heart FailureVol. 18(12)
Institutions
Brigham and Women's Hospital (US), British Heart Foundation (GB), AstraZeneca (Brazil) (BR), AstraZeneca (Finland) (FI), AstraZeneca (Spain) (ES)